The Chronic Idiopathic Constipation Treatment Market is witnessing steady momentum. Valued at USD 3.50 billion in 2024, the market is projected to reach USD 5.81 billion by 2032, expanding at a compound annual growth rate (CAGR) of 6.53% from 2025 to 2032. This article examines market dynamics, segmentation, drivers, challenges, and competitive strategies, drawing exclusively from...